Skip to main content
. 2024 Sep 17;2(1):33. doi: 10.1038/s44303-024-00037-z

Fig. 3. In vivo PET/CT pharmacokinetics and biodistribution using 68Gallium labelled probes.

Fig. 3

a Fused PET and CT images demonstrate the clearance pathway and segmentation of the organs for quantitative analysis. b, c Quantification of injected dose of the 68Ga-DOTAMA-CBP1 (b) and the 68Ga-DOTAMA-CBP2 (c) probes in the kidney, liver, and blood over time shows favourable pharmacokinetics. d Ex vivo radioactivity measurements show high kidney uptake and low uptake in all other tissues. T time post-injection (minutes).